14 - 17 Nov 2021 | Messe Düsseldorf, Germany

Abingdon Health is delighted to be attending Medica 2022.

Contact our team to discuss your lateral flow rapid test manufacturing and commercialisation needs.

Arrange A Meeting

LFT Manufacture: Contain risks and embrace opportunities

Gain peace of mind for your rapid test project and learn how our multi-disciplinary approach alongside operational excellence leads to the production of reliable products on-time and in-full (OTIF).

Whether working with newly developed lateral flow assays or tests already on the market, Abingdon Health helps its customers:

  • Transfer new and existing manufacturing Standard Operating Procedures into routine manufacture
  • Troubleshoot test performance and optimise test recipes and specifications
  • Conduct scale up from bench to automated manufacture
  • Navigate complex regulatory, legal, and commercial barriers to launching products to market

Reach new territories with a safe pair of hands

Reaching new territories with a lateral flow test (LFT) can be stressful, time-consuming and lead to expenditure instability. However, following decades in the LFT industry, Abingdon Health is well connected across Europe and globally, and offers LFT commercialisation solutions.

With either our ‘LFT product sales solution’ or our ‘LFT manufacturing (part or full) and sales solution’ we can help you increase your reach and market share while helping you to negate excessive expenditure and resourcing. We can take care of your commercialisation and/or your LFT manufacturing in Europe leaving you to focus on strategic goals and growth.



Book some time with us!

Complete the form below to book some time with us at Medica. See how our flexible solutions can help you move faster, contain risks and embrace opportunities!